Company News for Mar 16, 2026

Adobe Inc.’s ( ADBE) shares tumbled 7.6%, after the company announced that its longtime CEO Shantanu Narayen will step down once a successor is appointed. Shares of Meta Platforms Inc. ( META) slid 3.8% following news that the company has delayed the release of its new AI model "Avocado" to at least May.  Shares of Nektar Therapeutics ( NKTR) surged 4.1% after reporting fourth-quarter 2025 adjusted loss of $1.78 per share, narrower than the Zacks Consensus Estimate of an adjusted loss of $2.76 per share.  Oruka Therapeutics Inc.’s ( ORKA) shares soared 25% after posting fourth-quarter 2025 adjusted loss of $0.45 per share, narrower than the Zacks Consensus Estimate of an adjusted loss of $0.61 per share. 

 

Zacks' Research Chief Picks Stock Most Likely to "At Least Double"

Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.

See Our Top Stock to Double (Plus 4 Runners Up) >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 
Adobe Inc. (ADBE): Free Stock Analysis Report
 
Nektar Therapeutics (NKTR): Free Stock Analysis Report
 
Meta Platforms, Inc. (META): Free Stock Analysis Report
 
Oruka Therapeutics, Inc. (ORKA): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research